These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of vitamin D in multiple sclerosis. Brown SJ Ann Pharmacother; 2006 Jun; 40(6):1158-61. PubMed ID: 16684809 [TBL] [Abstract][Full Text] [Related]
3. Use of Vitamins and Dietary Supplements by Patients With Multiple Sclerosis: A Review. Evans E; Piccio L; Cross AH JAMA Neurol; 2018 Aug; 75(8):1013-1021. PubMed ID: 29710293 [TBL] [Abstract][Full Text] [Related]
4. Update on fat-soluble vitamins in cystic fibrosis. Maqbool A; Stallings VA Curr Opin Pulm Med; 2008 Nov; 14(6):574-81. PubMed ID: 18812835 [TBL] [Abstract][Full Text] [Related]
5. Fat-soluble vitamins and their importance in patients with cholestatic liver diseases. Sokol RJ Gastroenterol Clin North Am; 1994 Dec; 23(4):673-705. PubMed ID: 7698827 [TBL] [Abstract][Full Text] [Related]
6. [Recent changes in concepts of antioxidant treatment]. Matkovics A Orv Hetil; 2006 Apr; 147(16):747-52. PubMed ID: 16711261 [TBL] [Abstract][Full Text] [Related]
7. Vitamin D and its immunoregulatory role in multiple sclerosis. Niino M Drugs Today (Barc); 2010 Apr; 46(4):279-90. PubMed ID: 20502725 [TBL] [Abstract][Full Text] [Related]
8. The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis. James E; Dobson R; Kuhle J; Baker D; Giovannoni G; Ramagopalan SV Mult Scler; 2013 Oct; 19(12):1571-9. PubMed ID: 23698130 [TBL] [Abstract][Full Text] [Related]
9. Vitamin D and multiple sclerosis: can vitamin D prevent disease progression? Mehta B; Ramanathan M; Weinstock-Guttman B Expert Rev Neurother; 2011 Apr; 11(4):469-71. PubMed ID: 21469917 [No Abstract] [Full Text] [Related]
10. Vitamin D and multiple sclerosis—from epidemiology to prevention. Sundström P; Salzer J Acta Neurol Scand; 2015; 132(199):56-61. PubMed ID: 26046560 [TBL] [Abstract][Full Text] [Related]
11. Vitamin D and multiple sclerosis: a critical review and recommendations on treatment. Faridar A; Eskandari G; Sahraian MA; Minagar A; Azimi A Acta Neurol Belg; 2012 Dec; 112(4):327-33. PubMed ID: 22767049 [TBL] [Abstract][Full Text] [Related]
12. Oral absorbable fat-soluble vitamin formulation in pediatric patients with cholestasis. Shen YM; Wu JF; Hsu HY; Ni YH; Chang MH; Liu YW; Lai HS; Hsu WM; Weng HL; Chen HL J Pediatr Gastroenterol Nutr; 2012 Nov; 55(5):587-91. PubMed ID: 22595974 [TBL] [Abstract][Full Text] [Related]
13. [Vitamin D in Multiple Sclerosis]. Niino M; Miyazaki Y Brain Nerve; 2015 Nov; 67(11):1429-33. PubMed ID: 26560958 [TBL] [Abstract][Full Text] [Related]
16. Supplementation and therapeutic use of vitamin D in patients with multiple sclerosis: consensus of the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology. Brum DG; Comini-Frota ER; Vasconcelos CC; Dias-Tosta E Arq Neuropsiquiatr; 2014 Feb; 72(2):152-6. PubMed ID: 24604370 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Diseases and Fat Soluble Vitamins: Vitamin D and Vitamin K. Tsugawa N J Nutr Sci Vitaminol (Tokyo); 2015; 61 Suppl():S170-2. PubMed ID: 26598844 [TBL] [Abstract][Full Text] [Related]
18. Role of vitamin D in the onset, progression, and severity of multiple sclerosis. Mesliniene S; Ramrattan L; Giddings S; Sheikh-Ali M Endocr Pract; 2013; 19(1):129-36. PubMed ID: 23186958 [TBL] [Abstract][Full Text] [Related]
19. Fat-soluble vitamins and atopic disease: what is the evidence? Litonjua AA Proc Nutr Soc; 2012 Feb; 71(1):67-74. PubMed ID: 22114947 [TBL] [Abstract][Full Text] [Related]
20. Vitamins for Cardiovascular Diseases: Is the Expense Justified? Sultan S; Murarka S; Jahangir A; Mookadam F; Tajik AJ; Jahangir A Cardiol Rev; 2017; 25(6):298-308. PubMed ID: 28984669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]